gabapentin has been researched along with Phobic Disorders in 12 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin was given at a dose ranging from 25 to 30 mg/kg." | 3.01 | Effects of a single oral dose of gabapentin on storm phobia in dogs: A double-blind, placebo-controlled crossover trial. ( Bleuer-Elsner, S; Masson, S; Medam, T, 2021) |
| " Further studies are required to confirm this effect and to determine whether a dose-response relationship exists." | 2.69 | Treatment of social phobia with gabapentin: a placebo-controlled study. ( Davidson, JR; Greist, JH; Janney, CA; Jefferson, JW; Katzelnick, DJ; Pande, AC; Sutherland, SM; Weisler, RH, 1999) |
| "Pharmacologic treatments for panic disorder and social phobia have been available since the early 1960s." | 2.40 | Panic disorder and social phobia: current treatments and new strategies. ( Connor, KM; Davidson, JR; Sutherland, SM, 1998) |
| "Excessive sweating (hyperhidrosis) is an overlooked and potentially disabling symptom, which is often seen in social anxiety disorder (SAD)." | 1.31 | Hyperhidrosis in social anxiety disorder. ( Churchill, LE; Connor, KM; Davidson, JR; Foa, EB, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bleuer-Elsner, S | 1 |
| Medam, T | 1 |
| Masson, S | 1 |
| Orlando, JM | 1 |
| Robakis, TK | 1 |
| Davidson, JR | 4 |
| Foa, EB | 1 |
| Connor, KM | 3 |
| Churchill, LE | 1 |
| Blanco, C | 1 |
| Schneier, FR | 1 |
| Schmidt, A | 1 |
| Blanco-Jerez, CR | 1 |
| Marshall, RD | 1 |
| Sánchez-Lacay, A | 1 |
| Liebowitz, MR | 1 |
| Pollack, MH | 1 |
| Matthews, J | 1 |
| Scott, EL | 1 |
| Pande, AC | 1 |
| Jefferson, JW | 2 |
| Janney, CA | 1 |
| Katzelnick, DJ | 1 |
| Weisler, RH | 1 |
| Greist, JH | 1 |
| Sutherland, SM | 2 |
| Sutherland, S | 1 |
| Weisler, R | 1 |
| Durkin, JP | 1 |
3 reviews available for gabapentin and Phobic Disorders
| Article | Year |
|---|---|
Pharmacological treatment of social anxiety disorder: a meta-analysis.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Anxiety Disorders; C | 2003 |
Social phobia: issues in assessment and management.
Topics: Acetates; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-A | 1999 |
Panic disorder and social phobia: current treatments and new strategies.
Topics: Acetates; Amines; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cost-Benefit Analysis; Cycl | 1998 |
2 trials available for gabapentin and Phobic Disorders
| Article | Year |
|---|---|
Effects of a single oral dose of gabapentin on storm phobia in dogs: A double-blind, placebo-controlled crossover trial.
Topics: Amines; Analgesics; Animals; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dogs; Double-Blind Met | 2021 |
Treatment of social phobia with gabapentin: a placebo-controlled study.
Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Double-Blind Method; Fema | 1999 |
7 other studies available for gabapentin and Phobic Disorders
| Article | Year |
|---|---|
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal | 2017 |
Trypophobia Associated With Gabapentin: A Case Report.
Topics: Aged; Excitatory Amino Acid Antagonists; Female; Gabapentin; Humans; Paresthesia; Pattern Recognitio | 2018 |
Hyperhidrosis in social anxiety disorder.
Topics: Acetates; Adult; Amines; Calcium Channel Blockers; Clinical Trials as Topic; Clonazepam; Cognitive B | 2002 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |
Gabapentin. CI 945, GOE 3450, Neurontin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Area Under Curve; Biological Availability; Child; Child, P | 1999 |
Benzodiazepines and anticonvulsants for social phobia (social anxiety disorder).
Topics: Acetates; Alprazolam; Amines; Anticonvulsants; Benzodiazepines; Clinical Trials as Topic; Clonazepam | 2001 |
Gabapentin in complicated school refusal.
Topics: Acetates; Adolescent; Amines; Comorbidity; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, | 2002 |